These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1478002)

  • 41. Vaginally administered 16,16-dimethyl-PGE1-methyl ester (Gemeprost) to induce termination of pregnancy after the first trimester.
    Ford RM
    Aust N Z J Obstet Gynaecol; 1988 Aug; 28(3):169-71. PubMed ID: 3233078
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oral misoprostol versus vaginal gemeprost for cervical dilatation prior to vacuum aspiration in women in the sixth to twelfth week of gestation.
    Ngai SW; Yeung KC; Lao T; Ho PC
    Contraception; 1995 Jun; 51(6):347-50. PubMed ID: 7554974
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of medical abortion with surgical vacuum aspiration: women's preferences and acceptability of treatment.
    Henshaw RC; Naji SA; Russell IT; Templeton AA
    BMJ; 1993 Sep; 307(6906):714-7. PubMed ID: 8401094
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Induction of therapeutic abortion in early pregnancy with mifepristone in combination with prostaglandin pessary.
    Rodger MW; Baird DT
    Lancet; 1987 Dec; 2(8573):1415-8. PubMed ID: 2891991
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mifepristone (RU486) and therapeutic late pregnancy termination: a double-blind study of two different doses.
    Frydman R; Fernandez H; Pons JC; Ulmann A
    Hum Reprod; 1988 Aug; 3(6):803-6. PubMed ID: 3065355
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Medical abortion in women of less than or equal to 56 days amenorrhoea: a comparison between gemeprost (a PGE1 analogue) alone and mifepristone and gemeprost.
    Norman JE; Thong KJ; Rodger MW; Baird DT
    Br J Obstet Gynaecol; 1992 Jul; 99(7):601-6. PubMed ID: 1525104
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pregnancy termination: techniques, risks, and complications and their management.
    Castadot RG
    Fertil Steril; 1986 Jan; 45(1):5-17. PubMed ID: 3510916
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Gemeprost vaginal suppository for cervical priming prior to termination of first trimester pregnancy.
    Kajanoja P; Mandelin M; Mäkilä UM; Ylikorkala O; Felding C; Somell C; Olund A; Pedersen H
    Contraception; 1984 Mar; 29(3):251-60. PubMed ID: 6539662
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mid-trimester abortion by vaginal administration of 9-deoxo-16, 16-dimethyl-9-methylene-PGE2.
    Bygdeman M; Christensen N; Gréen K; Lundström V
    Contraception; 1980 Aug; 22(2):153-64. PubMed ID: 7449380
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intramuscular administration of 16 phenoxy omega 17,18,19,20 tetranor PGE2 methyl sulfonylamide for pre-operative cervical dilatation in first trimester nulliparae.
    Karim SM; Ilancheran A; Wun W; Ho TH; Ratnam SS
    Prostaglandins Med; 1978 Jul; 1(1):71-5. PubMed ID: 715049
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cervical dilatation with prostaglandin analogues prior to vaginal termination of first trimester pregnancy in nulliparous patients.
    Karim SM; Choo HT; Cheng P
    Prostaglandins; 1975 Apr; 9(4):631-8. PubMed ID: 1153813
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The use of progesterone antagonists in combination with prostaglandin for termination of pregnancy.
    Bygdeman M; Swahn ML; Gemzell-Danielsson K; Gottlieb C
    Hum Reprod; 1994 Jun; 9 Suppl 1():121-5. PubMed ID: 7962458
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of oral prostaglandin E2 on uterine contractility and outcome of treatment in women receiving RU 486 (mifepristone) for termination of early pregnancy.
    Swahn ML; Ugocsai G; Bygdeman M; Kovacs L; Belsey EM; Van Look PF
    Hum Reprod; 1989 Jan; 4(1):21-8. PubMed ID: 2651472
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Blood loss in termination of early pregnancy with mifepristone and gemeprost.
    Prasad RN; Choolani M; Roy A; Ratnam SS
    Aust N Z J Obstet Gynaecol; 1995 Aug; 35(3):329-31. PubMed ID: 8546658
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Termination of second trimester pregnancy by intramuscular injection of 16-phenoxy-omega-17,18,19,20-tetranor-PGE2 methyl sulphonylamide.
    Int J Gynaecol Obstet; 1982 Oct; 20(5):383-6. PubMed ID: 6128270
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vaginally administered 16, 16-dimethyl-prostaglandin E2 as an agent for pre-operative cervical dilatation.
    Leader A; Bygdeman M; Gréen K; Martin JN; Wiqvist N
    Prostaglandins; 1975 Aug; 10(2):357-64. PubMed ID: 1178913
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Termination of second trimester pregnancy with sulprostone and mifepristone: a randomized double-blind placebo-controlled trial.
    Ho PC; Ma HK
    Contraception; 1993 Feb; 47(2):123-9. PubMed ID: 8449013
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A comparison of medical abortion (using mifepristone and gemeprost) with surgical vacuum aspiration: efficacy and early medical sequelae.
    Henshaw RC; Naji SA; Russell IT; Templeton AA
    Hum Reprod; 1994 Nov; 9(11):2167-72. PubMed ID: 7868693
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sulprostone for preoperative cervical dilatation in primigravidae scheduled for late first trimester termination of pregnancy.
    Jerve F; Fylling P
    Arch Gynecol; 1983; 233(3):199-203. PubMed ID: 6625666
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The use of antiprogestin (RU 486) for termination of second trimester pregnancy.
    Gottlieb C; Bygdeman M
    Acta Obstet Gynecol Scand; 1991; 70(3):199-203. PubMed ID: 1927296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.